{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:30:09Z","timestamp":1786120209500,"version":"build-2736575974"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1097\/inf.0b013e31823dcc72","type":"journal-article","created":{"date-parts":[[2011,11,18]],"date-time":"2011-11-18T06:19:56Z","timestamp":1321597196000},"page":"228-234","source":"Crossref","is-referenced-by-count":43,"title":["The Changing Epidemiology of Invasive Pneumococcal Disease at a Tertiary Children's Hospital Through the 7-valent Pneumococcal Conjugate Vaccine Era"],"prefix":"10.1097","volume":"31","author":[{"given":"Krow","family":"Ampofo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"Pavia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Stockmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam L.","family":"Hersh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Bender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne J.","family":"Blaschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin Yi Cindy","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent E.","family":"Korgenski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward O.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie L.","family":"Byington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-5-20210202","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/521626","article-title":". Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.","volume":"196","author":"Hicks","year":"2007","journal-title":"J Infect Dis"},{"key":"R3-5-20210202","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1086\/430604","article-title":". Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.","volume":"41","author":"Byington","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R4-5-20210202","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1001\/jama.297.16.1784","article-title":". Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage.","volume":"297","author":"Singleton","year":"2007","journal-title":"JAMA"},{"key":"R5-5-20210202","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/thx.2003.016105","article-title":". Clinical features, aetiology and outcome of empyema in children in the north east of England.","volume":"59","author":"Eastham","year":"2004","journal-title":"Thorax"},{"key":"R6-5-20210202","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/01.inf.0000235684.89728.38","article-title":". Molecular typing of pneumococci causing parapneumonic empyema in Spanish children using multilocus sequence typing directly on pleural fluid samples.","volume":"25","author":"Obando","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R7-5-20210202","first-page":"1210","article-title":"Prevention of pneumococcal disease by vaccination: does serotype replacement matter Lancet.","volume":"356","author":"Spratt","year":"2000","journal-title":""},{"key":"R8-5-20210202","first-page":"258","article-title":"Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among childrenAdvisory Committee on Immunization Practices (ACIP), 2010.","volume":"59","year":"2010","journal-title":"Morb Mortal Wkly Rep"},{"issue":"RR-9","key":"R9-5-20210202","first-page":"1","article-title":"Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices.","volume":"49","year":"2000","journal-title":"Morb Mortal Wkly Rep"},{"key":"R11-5-20210202","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/INF.0b013e3181c2a229","article-title":". Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas.","volume":"29","author":"Techasaensiri","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R12-5-20210202","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":". Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"R14-5-20210202","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1086\/503805","article-title":". Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease.","volume":"193","author":"Hammitt","year":"2006","journal-title":"J Infect Dis"},{"key":"R15-5-20210202","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1097\/INF.0b013e318232ee3e","article-title":". Evolution of the epidemiology of pneumococcal disease among Utah children through the vaccine era.","volume":"30","author":"Ampofo","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R16-5-20210202","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00431-010-1195-6","article-title":"Pediatric complicated pneumonia and pneumococcal serotype replacement: trends in hospitalized children pre and post introduction of routine vaccination with pneumococcal conjugate vaccine (PCV7).","volume":"169","author":"Chibuk","year":"2010","journal-title":"Eur J Pediatr"},{"key":"R17-5-20210202","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1542\/peds.2009-0184","article-title":"Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine.","volume":"125","author":"Li","year":"2010","journal-title":"Pediatrics"},{"key":"R18-5-20210202","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(06)69637-2","article-title":". Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study.","volume":"368","author":"Whitney","year":"2006","journal-title":"Lancet"},{"key":"R20-5-20210202","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMoa035060","article-title":". A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection.","volume":"349","author":"Klugman","year":"2003","journal-title":"N Engl J Med"},{"key":"R21-5-20210202","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/cid\/cir326","article-title":". Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States.","volume":"53","author":"Rosen","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R22-5-20210202","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa0800836","article-title":". Effect of pneumococcal conjugate vaccine on pneumococcal meningitis.","volume":"360","author":"Hsu","year":"2009","journal-title":"N Engl J Med"},{"key":"R23-5-20210202","first-page":"1077","article-title":"Emergence of antimicrobial-resistant serotype 19A Streptococcus pneumoniaeMassachusetts, 2001-2006.","volume":"56","year":"2007","journal-title":"Morb Mortal Wkly Rep"},{"key":"R24-5-20210202","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1086\/498043","article-title":". Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States.","volume":"192","author":"Pai","year":"2005","journal-title":"J Infect Dis"},{"key":"R25-5-20210202","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1086\/528996","article-title":". Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.","volume":"197","author":"Moore","year":"2008","journal-title":"J Infect Dis"},{"key":"R26-5-20210202","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1542\/peds.2008-1702","article-title":". Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children.","volume":"125","author":"Kaplan","year":"2010","journal-title":"Pediatrics"},{"key":"R27-5-20210202","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1086\/592972","article-title":". Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine.","volume":"47","author":"Jacobs","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R28-5-20210202","first-page":"1346","article-title":"Korgenski K, et al..","volume":"46","author":"Bender","year":"2008","journal-title":"Pneumococcal necrotizing pneumonia in Utah: does serotype matter Clin Infect Dis"},{"key":"R29-5-20210202","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1086\/524660","article-title":". Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine.","volume":"46","author":"Munoz-Almagro","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R30-5-20210202","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/01.inf.0000202137.37642.ab","article-title":". Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema.","volume":"25","author":"Byington","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R31-5-20210202","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.3201\/eid1409.071094","article-title":". Pediatric parapneumonic empyema, Spain.","volume":"14","author":"Obando","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"R32-5-20210202","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":". Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"key":"R33-5-20210202","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1086\/422653","article-title":". Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in Tennessee after introduction of the pneumococcal conjugate vaccine.","volume":"39","author":"Talbot","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R34-5-20210202","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/01.inf.0000069761.11093.c3","article-title":". Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers.","volume":"22","author":"Dagan","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R35-5-20210202","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/jama.2009.1163","article-title":"Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings.","volume":"302","author":"Grijalva","year":"2009","journal-title":"JAMA"},{"key":"R36-5-20210202","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/infdis\/jir052","article-title":". Shifting genetic structure of invasive serotype 19A pneumococci in the United States.","volume":"203","author":"Beall","year":"2011","journal-title":"J Infect Dis"},{"key":"R37-5-20210202","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1128\/AAC.01494-10","article-title":". Evolution of clonal and susceptibility profiles of serotype 19A Streptococcus pneumoniae among invasive isolates from children in Spain, 1990 to 2008.","volume":"55","author":"Tarrago","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"R38-5-20210202","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/jac\/dkn538","article-title":". Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.","volume":"63","author":"Harrison","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"R39-5-20210202","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1017\/S0950268804003565","article-title":". Penicillin-resistant pneumococcal meningitis: high antibiotic exposure impedes new vaccine protection.","volume":"133","author":"Temime","year":"2005","journal-title":"Epidemiol Infect"},{"key":"R40-5-20210202","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/INF.0b013e3182002d14","article-title":". Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema.","volume":"30","author":"Blaschke","year":"2011","journal-title":"Pediatr Infect Dis J"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0b013e31823dcc72","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:26:19Z","timestamp":1786047979000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201203000-00005"}},"subtitle":["A Case for Continuous Surveillance"],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e31823dcc72","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}